Tag: Qilu Pharmaceutical Group

Regor Therapeutics raises $90m for CARD platform in Series B funding round

pallavi123- February 23, 2021

Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of drugs for cancer, immune disorders, and metabolic ... Read More